Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...

In the United States, more than half of people living with HIV are now age 50 and older, which is a testament to the success of advancements such as antiretrovirals and preexposure anaphylaxis.

HPV vaccine remains effective in preventing infections and related cancers, even with incomplete dosing, 17 years after its ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

An expert discusses the critical need for a holistic, multidisciplinary approach to prevent and manage interconnected ...

AI models outperform traditional rule-based systems in identifying high-risk patients by integrating diverse data sources and ...

Dry eye treatments include over-the-counter eye drops and prescription medicines. The AMCP abstract included immunomodulators ...

Among chemotherapy-naive patients, elacestrant extended median progression-free survival compared with standard therapy, ...

Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.

In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

Shawn Kwatra, M.D., Joseph W. Burnett endowed professor and chair of dermatology at the University of Maryland School of ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...